Optimapharm
Medical Device
Partnered on
81
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
81
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Marketed Medical Devices
Across
57
Projects
Enrolled
2,000
Subjects

Partner with a global medical device CRO supporting studies across multiple therapeutic areas through integrated therapeutic platforms and a differentiated global footprint. Our experienced operational and regulatory teams work closely with you to expand patient access, navigate regional regulatory pathways, and deliver consistent, high-quality execution of medical device and diagnostic studies worldwide

Integrated Therapeutic Platforms Across Multiple Indications

Supporting medical device and diagnostic studies across diverse therapeutic areas with connected, scalable delivery models

Cardiology
Cardiology Text
Immunology
Immunology Text
Dermatology
Dermatology Text
Oncology
Oncology Text
Neurology
Neurology Text

Global MDR, PMCF & IDE Clinical Support

The EU Medical Device Regulation (EU MDR 2017/745) has raised the bar for clinical evidence and lifecycle oversight of medical devices. Manufacturers are now required to take a more rigorous and continuous approach to clinical investigations and post-market clinical follow-up (PMCF). Optimapharm supports MDR-compliant clinical investigations and PMCF studies across the EU, IDE approvals in the US, and regulatory activities worldwide, helping manufacturers meet evolving requirements with confidence.

Medical Devices & Diagnostics Support

Differentiated Global Footprint for Broader Patient Access

Expanding access to patients and regions through established global presence and local market expertise

2x

2x more reach across North America and Europe than the average mid-sized CRO

Additional Services

Resource Hub